Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D3 plus nicotine

Jonghoon Park, Naomi Omi, Motoyuki Iemitsu, Seiji Maeda, Ayako Kitajima, Toshiya Nosaka, Ikuko Ezawa

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Epidemiological studies have reported an association between arterial calcification and bone loss after menopause. However, the underlying mechanism of the association remains unclear. Therefore, to explore the possible mechanisms of the association, we tried to develop a new combined model rat of ovariectomy (OVX, an animal model of osteoporosis) and vitamin D3 plus nicotine (VDN rat, an animal model of arterial calcification). We tested them by using sham-operated control rats (SC), OVX control rats (OC), and OVX plus VDN-treated rats (OVN). Dissections were performed twice at 4 (4SC, 4OC, and 4OVN) and 8 (8SC, 8OC, and 8OVN) weeks after treatment. 8OVN showed bone loss and arterial calcification, although 8OC showed only bone loss. Moreover, arterial calcium content was associated with indexes of bone loss at 8 weeks. Thus, the OVN rat is considered a good model to examine the relationship of the two disorders after menopause. Additionally, the arterial endothelin-1 (ET-1, a potent regulator of arterial calcification) levels increased in both 4OVN and 8OVN, and the level was associated with arterial calcium content at 8 weeks. Furthermore, the arterial endothelial nitric oxide synthase (eNOS) protein, which is an enzyme that produces nitric oxide (an antiatherosclerotic substance), was significantly reduced in only 8OVN. Estrogens affect the alterations of the eNOS and ET-1 proteins. Therefore, we suggest that impairment of the ET-1- and NO-producing system in arterial tissue during periods of rapid bone loss by estrogen deficiency might be a mechanism of the relationship between the two disorders seen in postmenopausal women.

Original languageEnglish
Pages (from-to)192-201
Number of pages10
JournalCalcified Tissue International
Volume83
Issue number3
DOIs
Publication statusPublished - 2008 Sep 1
Externally publishedYes

Fingerprint

Cholecalciferol
Ovariectomy
Nicotine
Bone and Bones
Nitric Oxide Synthase Type III
Menopause
Estrogens
Animal Models
Calcium
Endothelin-1
Osteoporosis
Dissection
Epidemiologic Studies
Nitric Oxide
Proteins
Enzymes

Keywords

  • Osteoporosis
  • Rat
  • Vascular calcification

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Endocrinology

Cite this

Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D3 plus nicotine. / Park, Jonghoon; Omi, Naomi; Iemitsu, Motoyuki; Maeda, Seiji; Kitajima, Ayako; Nosaka, Toshiya; Ezawa, Ikuko.

In: Calcified Tissue International, Vol. 83, No. 3, 01.09.2008, p. 192-201.

Research output: Contribution to journalArticle

Park, Jonghoon ; Omi, Naomi ; Iemitsu, Motoyuki ; Maeda, Seiji ; Kitajima, Ayako ; Nosaka, Toshiya ; Ezawa, Ikuko. / Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D3 plus nicotine. In: Calcified Tissue International. 2008 ; Vol. 83, No. 3. pp. 192-201.
@article{2fb5a9db6f1f4471903e37af1dc5a5ce,
title = "Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D3 plus nicotine",
abstract = "Epidemiological studies have reported an association between arterial calcification and bone loss after menopause. However, the underlying mechanism of the association remains unclear. Therefore, to explore the possible mechanisms of the association, we tried to develop a new combined model rat of ovariectomy (OVX, an animal model of osteoporosis) and vitamin D3 plus nicotine (VDN rat, an animal model of arterial calcification). We tested them by using sham-operated control rats (SC), OVX control rats (OC), and OVX plus VDN-treated rats (OVN). Dissections were performed twice at 4 (4SC, 4OC, and 4OVN) and 8 (8SC, 8OC, and 8OVN) weeks after treatment. 8OVN showed bone loss and arterial calcification, although 8OC showed only bone loss. Moreover, arterial calcium content was associated with indexes of bone loss at 8 weeks. Thus, the OVN rat is considered a good model to examine the relationship of the two disorders after menopause. Additionally, the arterial endothelin-1 (ET-1, a potent regulator of arterial calcification) levels increased in both 4OVN and 8OVN, and the level was associated with arterial calcium content at 8 weeks. Furthermore, the arterial endothelial nitric oxide synthase (eNOS) protein, which is an enzyme that produces nitric oxide (an antiatherosclerotic substance), was significantly reduced in only 8OVN. Estrogens affect the alterations of the eNOS and ET-1 proteins. Therefore, we suggest that impairment of the ET-1- and NO-producing system in arterial tissue during periods of rapid bone loss by estrogen deficiency might be a mechanism of the relationship between the two disorders seen in postmenopausal women.",
keywords = "Osteoporosis, Rat, Vascular calcification",
author = "Jonghoon Park and Naomi Omi and Motoyuki Iemitsu and Seiji Maeda and Ayako Kitajima and Toshiya Nosaka and Ikuko Ezawa",
year = "2008",
month = "9",
day = "1",
doi = "10.1007/s00223-008-9162-1",
language = "English",
volume = "83",
pages = "192--201",
journal = "Calcified Tissue International",
issn = "0171-967X",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D3 plus nicotine

AU - Park, Jonghoon

AU - Omi, Naomi

AU - Iemitsu, Motoyuki

AU - Maeda, Seiji

AU - Kitajima, Ayako

AU - Nosaka, Toshiya

AU - Ezawa, Ikuko

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Epidemiological studies have reported an association between arterial calcification and bone loss after menopause. However, the underlying mechanism of the association remains unclear. Therefore, to explore the possible mechanisms of the association, we tried to develop a new combined model rat of ovariectomy (OVX, an animal model of osteoporosis) and vitamin D3 plus nicotine (VDN rat, an animal model of arterial calcification). We tested them by using sham-operated control rats (SC), OVX control rats (OC), and OVX plus VDN-treated rats (OVN). Dissections were performed twice at 4 (4SC, 4OC, and 4OVN) and 8 (8SC, 8OC, and 8OVN) weeks after treatment. 8OVN showed bone loss and arterial calcification, although 8OC showed only bone loss. Moreover, arterial calcium content was associated with indexes of bone loss at 8 weeks. Thus, the OVN rat is considered a good model to examine the relationship of the two disorders after menopause. Additionally, the arterial endothelin-1 (ET-1, a potent regulator of arterial calcification) levels increased in both 4OVN and 8OVN, and the level was associated with arterial calcium content at 8 weeks. Furthermore, the arterial endothelial nitric oxide synthase (eNOS) protein, which is an enzyme that produces nitric oxide (an antiatherosclerotic substance), was significantly reduced in only 8OVN. Estrogens affect the alterations of the eNOS and ET-1 proteins. Therefore, we suggest that impairment of the ET-1- and NO-producing system in arterial tissue during periods of rapid bone loss by estrogen deficiency might be a mechanism of the relationship between the two disorders seen in postmenopausal women.

AB - Epidemiological studies have reported an association between arterial calcification and bone loss after menopause. However, the underlying mechanism of the association remains unclear. Therefore, to explore the possible mechanisms of the association, we tried to develop a new combined model rat of ovariectomy (OVX, an animal model of osteoporosis) and vitamin D3 plus nicotine (VDN rat, an animal model of arterial calcification). We tested them by using sham-operated control rats (SC), OVX control rats (OC), and OVX plus VDN-treated rats (OVN). Dissections were performed twice at 4 (4SC, 4OC, and 4OVN) and 8 (8SC, 8OC, and 8OVN) weeks after treatment. 8OVN showed bone loss and arterial calcification, although 8OC showed only bone loss. Moreover, arterial calcium content was associated with indexes of bone loss at 8 weeks. Thus, the OVN rat is considered a good model to examine the relationship of the two disorders after menopause. Additionally, the arterial endothelin-1 (ET-1, a potent regulator of arterial calcification) levels increased in both 4OVN and 8OVN, and the level was associated with arterial calcium content at 8 weeks. Furthermore, the arterial endothelial nitric oxide synthase (eNOS) protein, which is an enzyme that produces nitric oxide (an antiatherosclerotic substance), was significantly reduced in only 8OVN. Estrogens affect the alterations of the eNOS and ET-1 proteins. Therefore, we suggest that impairment of the ET-1- and NO-producing system in arterial tissue during periods of rapid bone loss by estrogen deficiency might be a mechanism of the relationship between the two disorders seen in postmenopausal women.

KW - Osteoporosis

KW - Rat

KW - Vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=52649150797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52649150797&partnerID=8YFLogxK

U2 - 10.1007/s00223-008-9162-1

DO - 10.1007/s00223-008-9162-1

M3 - Article

C2 - 18758843

AN - SCOPUS:52649150797

VL - 83

SP - 192

EP - 201

JO - Calcified Tissue International

JF - Calcified Tissue International

SN - 0171-967X

IS - 3

ER -